go-v.orgdoi

RNase: A Novel Enzyme For Treatment Of Cancers

— · The Internet Journal of Oncology · 2008

  • DOI 10.5580/8fb
  • Publisher OpenAlex
  • Type article
  • Issued 2008

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

The Internet Journal of Oncology · OpenAlex · article · 2008

Abstract

Ribonucleases (RNase) catalyses the breakdown of RNA into smaller components. The cytotoxic effects of RNase include the RNA cleavage leading to the inhibition of the protein synthesis and the induction of apoptosis. RNases uniquely influence several functions in the tumor cell simultaneously and demonstrated the ability to overcome multi-drug resistance and to enhance the cytotoxicity of a variety of anti-cancer agents. Different RNases such as onconases, bovine seminal RNase, RNase T1, α-sarcin, RNase P, actibind and RNaseT2 have recently been studied for the treatment of different type of cancers.

Open the resolved locator · 10.5580/8fb

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 01:04 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.5580/8fb
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.